Ritlecitinib (Standard)

(Synonyms: PF-06651600 (Standard))
1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

Ritlecitinib (Standard) is the analytical standard of Ritlecitinib (HY-100754). This product is intended for research and analytical applications. Ritlecitinib (PF-06651600) is a highly selective, orally active, irreversible covalent JAK3 inhibitor (IC50=33 nM) without inhibitory activity towards JAK1, JAK2, and TYK2 (IC50 >10 μ M). Ritlecitinib rapidly inactivates the JAK3 kinase, and blocks signaling and downstream STAT phosphorylation mediated by common gamma chain cytokines such as IL-2 and IL-15. Ritlecitinib can inhibit Th1/Th17 cell differentiation and function, and effectively suppress preclinical animal models such as alopecia areata, adjuvant-induced arthritis (AIA), and experimental autoimmune encephalomyelitis (EAE).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 95%
  • CAS. Nr.: 1792180-81-4
  • Formel: C15H19N5O
  • Molecular Weight:285.35
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Reinheit & Dokumentation
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Ritlecitinib (Standard)

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00